Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.
2.

The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression.

Montag C, Wagner JA, Gruska I, Vetter B, Wiebusch L, Hagemeier C.

J Virol. 2011 Nov;85(21):11409-21. doi: 10.1128/JVI.05028-11. Epub 2011 Aug 31.

3.

A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection.

Umashankar M, Petrucelli A, Cicchini L, Caposio P, Kreklywich CN, Rak M, Bughio F, Goldman DC, Hamlin KL, Nelson JA, Fleming WH, Streblow DN, Goodrum F.

PLoS Pathog. 2011 Dec;7(12):e1002444. doi: 10.1371/journal.ppat.1002444. Epub 2011 Dec 29.

4.

Interactions between proteins encoded within the human cytomegalovirus UL133-UL138 locus.

Petrucelli A, Umashankar M, Zagallo P, Rak M, Goodrum F.

J Virol. 2012 Aug;86(16):8653-62. doi: 10.1128/JVI.00465-12. Epub 2012 Jun 6.

5.

Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infection.

Umashankar M, Rak M, Bughio F, Zagallo P, Caviness K, Goodrum FD.

J Virol. 2014 Jun;88(11):5987-6002. doi: 10.1128/JVI.03506-13. Epub 2014 Mar 12.

6.

The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.

Wang D, Li G, Schauflinger M, Nguyen CC, Hall ED, Yurochko AD, von Einem J, Kamil JP.

J Virol. 2013 Jun;87(11):6359-76. doi: 10.1128/JVI.03477-12. Epub 2013 Mar 27.

8.

Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.

Ndour PA, Ouk TS, Brocqueville G, Mougel A, Vanhecke E, Feuillard J, Coll J, Adriaenssens E.

Cell Signal. 2010 Feb;22(2):303-13. doi: 10.1016/j.cellsig.2009.09.037. Epub 2009 Sep 29.

PMID:
19796681
9.

Staphylococcus aureus induces the expression of tumor necrosis factor-alpha in primary human keratinocytes.

Aufiero B, Guo M, Young C, Duanmu Z, Talwar H, Lee HK, Murakawa GJ.

Int J Dermatol. 2007 Jul;46(7):687-94.

PMID:
17614795
10.

Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication.

Buehler J, Zeltzer S, Reitsma J, Petrucelli A, Umashankar M, Rak M, Zagallo P, Schroeder J, Terhune S, Goodrum F.

PLoS Pathog. 2016 May 24;12(5):e1005655. doi: 10.1371/journal.ppat.1005655. eCollection 2016 May.

11.

Astrocyte reactivity to unconjugated bilirubin requires TNF-α and IL-1β receptor signaling pathways.

Fernandes A, Barateiro A, Falcão AS, Silva SL, Vaz AR, Brito MA, Silva RF, Brites D.

Glia. 2011 Jan;59(1):14-25. doi: 10.1002/glia.21072. Epub 2010 Oct 21.

PMID:
20967881
13.

Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.

Sprowl JA, Reed K, Armstrong SR, Lanner C, Guo B, Kalatskaya I, Stein L, Hembruff SL, Tam A, Parissenti AM.

Breast Cancer Res. 2012 Jan 6;14(1):R2.

14.

The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.

Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ.

J Biol Chem. 2002 Jun 14;277(24):21730-9. Epub 2002 Apr 4.

15.
16.

Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.

Mukai Y, Shibata H, Nakamura T, Yoshioka Y, Abe Y, Nomura T, Taniai M, Ohta T, Ikemizu S, Nakagawa S, Tsunoda S, Kamada H, Yamagata Y, Tsutsumi Y.

J Mol Biol. 2009 Jan 30;385(4):1221-9. doi: 10.1016/j.jmb.2008.11.053. Epub 2008 Dec 6.

PMID:
19084540
17.
19.

TNF receptor independent activation of the cytomegalovirus major immediate early enhancer in response to transplantation.

Zhang Z, Kim SJ, Varghese T, Thomas G, Hummel M, Abecassis M.

Transplantation. 2008 Apr 15;85(7):1039-45. doi: 10.1097/TP.0b013e318168449c.

PMID:
18408586
20.

Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis.

Reuss R, Pohle S, Retzlaff K, Hemberger J, Oschmann P.

Neuroimmunomodulation. 2009;16(3):171-6. doi: 10.1159/000204230. Epub 2009 Feb 24.

PMID:
19246939

Supplemental Content

Support Center